Current Status of Treatment for Patients with Crohn's Disease with Reference to the Japanese Guideline

Abstract

Crohn's disease (CD) is a chronic inflammatory disorder characterized by a disabling and interactive course. Treatments for patients with CD have been developed and effective therapies, such as Infliximab, have been widely used in Japan. Therefore, physicians are required to choose an optimal treatment for each patient. The Japanese guideline for CD, consisting of not only evidence but also the consensus of specialists, was published in April 2010. This article introduces the treatments for CD described in the guideline and their proper use.